|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/107 | (2006.01) |
| A61K 9/48 | (2006.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 47/14 | (2017.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/26 | (2006.01) |
| (11) | Patento numeris | 3463298 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17805885.5 |
| Europos patento paraiškos padavimo data | 2017-06-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/086942 |
| Data | 2017-06-02 |
| (87) | Numeris | WO 2017/206940 |
| Data | 2017-12-07 |
| (30) | Numeris | Data | Šalis |
| 201662344660 P | 2016-06-02 | US |
| (72) |
HAO, Wei-Hua , TW
HSUEH, Shu-Piing , TW
HSU, Chang-Shan , TW
|
| (73) |
Innopharmax, Inc. ,
9F., No.22, Lane 478
Rueiguang Rd.
Neihu District, Taipei City 11492,
TW
|
| (54) | METRONOMIC ORAL GEMCITABINE FOR CANCER THERAPY |
| METRONOMIC ORAL GEMCITABINE FOR CANCER THERAPY |